Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 3
1988 2
1989 2
1990 3
1991 7
1992 7
1993 1
1995 3
1996 1
1997 6
1998 1
1999 4
2000 1
2001 1
2002 3
2003 1
2004 2
2005 1
2006 2
2007 3
2008 2
2009 4
2010 3
2011 9
2012 6
2013 13
2014 7
2015 2
2016 11
2017 8
2018 3
2019 2
2020 6
2021 5
2022 6
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Structural insights into the role and targeting of EGFRvIII.
Bagchi A, Stayrook SE, Xenaki KT, Starbird CA, Doulkeridou S, El Khoulati R, Roovers RC, Schmitz KR, van Bergen En Henegouwen PMP, Ferguson KM. Bagchi A, et al. Among authors: van bergen en henegouwen pmp. Structure. 2024 Sep 5;32(9):1367-1380.e6. doi: 10.1016/j.str.2024.05.018. Epub 2024 Jun 21. Structure. 2024. PMID: 38908376
Bispecific antibody platforms for cancer immunotherapy.
Lameris R, de Bruin RC, Schneiders FL, van Bergen en Henegouwen PM, Verheul HM, de Gruijl TD, van der Vliet HJ. Lameris R, et al. Among authors: van bergen en henegouwen pm. Crit Rev Oncol Hematol. 2014 Dec;92(3):153-65. doi: 10.1016/j.critrevonc.2014.08.003. Epub 2014 Aug 20. Crit Rev Oncol Hematol. 2014. PMID: 25195094 Review.
Nanobody-based cancer therapy of solid tumors.
Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM. Kijanka M, et al. Among authors: van bergen en henegouwen pm. Nanomedicine (Lond). 2015 Jan;10(1):161-74. doi: 10.2217/nnm.14.178. Nanomedicine (Lond). 2015. PMID: 25597775 Review.
MAGE-A antigens as targets for cancer immunotherapy.
Schooten E, Di Maggio A, van Bergen En Henegouwen PMP, Kijanka MM. Schooten E, et al. Among authors: van bergen en henegouwen pmp. Cancer Treat Rev. 2018 Jun;67:54-62. doi: 10.1016/j.ctrv.2018.04.009. Epub 2018 Apr 26. Cancer Treat Rev. 2018. PMID: 29763778 Review.
Nanobodies in therapeutic applications.
Roovers RC, van Dongen GA, van Bergen en Henegouwen PM. Roovers RC, et al. Among authors: van bergen en henegouwen pm. Curr Opin Mol Ther. 2007 Aug;9(4):327-35. Curr Opin Mol Ther. 2007. PMID: 17694445 Review.
Resolving bundled microtubules using anti-tubulin nanobodies.
Mikhaylova M, Cloin BM, Finan K, van den Berg R, Teeuw J, Kijanka MM, Sokolowski M, Katrukha EA, Maidorn M, Opazo F, Moutel S, Vantard M, Perez F, van Bergen en Henegouwen PM, Hoogenraad CC, Ewers H, Kapitein LC. Mikhaylova M, et al. Among authors: van bergen en henegouwen pm. Nat Commun. 2015 Aug 11;6:7933. doi: 10.1038/ncomms8933. Nat Commun. 2015. PMID: 26260773 Free PMC article.
Multifaceted Activities of Seven Nanobodies against Complement C4b.
De la O Becerra KI, Oosterheert W, van den Bos RM, Xenaki KT, Lorent JH, Ruyken M, Schouten A, Rooijakkers SHM, van Bergen En Henegouwen PMP, Gros P. De la O Becerra KI, et al. Among authors: van bergen en henegouwen pmp. J Immunol. 2022 May 1;208(9):2207-2219. doi: 10.4049/jimmunol.2100647. Epub 2022 Apr 15. J Immunol. 2022. PMID: 35428691 Free PMC article.
Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM. Oliveira S, et al. Among authors: van bergen en henegouwen pm. J Control Release. 2013 Dec 28;172(3):607-17. doi: 10.1016/j.jconrel.2013.08.298. Epub 2013 Sep 11. J Control Release. 2013. PMID: 24035975 Review.
137 results